|
注册号: Registration number: |
ChiCTR2000031860 |
|
最近更新日期: Date of Last Refreshed on: |
2020-04-12 21:07:29 |
|
注册时间: Date of Registration: |
2020-04-12 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
运动康复对新型冠状病毒肺炎(COVID-19)出院患者功能障碍影响的研究 |
|
Public title: |
Study for the exercise rehabilitation therapy for the dysfunction of cured discharged novel coronavirus pneumonia (COVID-19) patients |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
运动康复对新型冠状病毒肺炎(COVID-19)出院患者功能障碍影响的研究 |
|
Scientific title: |
Study for the exercise rehabilitation therapy for the dysfunction of cured discharged novel coronavirus pneumonia (COVID-19) patients |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
高梓诚 |
研究负责人: |
钱菁华 |
|
Applicant: |
Zicheng Gao |
Study leader: |
Jinghua Qian |
|
申请注册联系人电话: Applicant telephone: |
+86 18810067075 |
研究负责人电话:
Study leader's |
+86 18600819602 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
836289519@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
ydkfedu@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
北京市海淀区信息路48号 |
研究负责人通讯地址: |
北京市海淀区信息路48号 |
|
Applicant address: |
48 Xinxi Road, Haidian District, Beijing, China |
Study leader's address: |
48 Xinxi Road, Haidian District, Beijing, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
北京体育大学 |
||
|
Applicant's institution: |
Beijing Sports University |
||
|
研究负责人所在单位: |
北京体育大学 |
||
|
Affiliation of the Leader: |
Beijing Sports University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
HRWGZYY2020003 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
华润武钢总医院医学伦理委员会 |
||
|
Name of the ethic committee: |
The medical ethic committee of China Resources & WISCO General Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2020-04-03 00:00:00 | ||
|
伦理委员会联系人: |
杨唐柱 |
||
|
Contact Name of the ethic committee: |
Tangzhu Yang |
||
|
伦理委员会联系地址: |
湖北省武汉市青山区冶金大道209号 |
||
|
Contact Address of the ethic committee: |
209 Yejin Avenue, Qingshan District, Wuhan, Hubei, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 027-86212358 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
北京体育大学 |
||||||||||||||||||||||
|
Primary sponsor: |
Beijing Sports University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
北京市海淀区信息路48号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
48 Xinxi Road, Haidian District, Beijing, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
运动促进心肺功能康复研究中心 |
||||||||||||||||||||||
|
Source(s) of funding: |
Exercise for Cardiopulmonary Rehabilitation Research Center |
||||||||||||||||||||||
|
研究疾病: |
新型冠状病毒肺炎(COVID-19) |
||||||||||||||||||||||
|
Target disease: |
Novel Coronavirus Pneumonia (COVID-19) |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
非随机对照试验 |
||||||||||||||||||||||
|
Study design: |
Non randomized control |
||||||||||||||||||||||
|
研究目的: |
研究目的是建立新冠肺炎运动康复队列,分析康复治疗对患者心肺功能、运动功能、日常生活活动能力、心理及生活质量的治疗效果,为新冠肺炎运动康复方法的制定提供循证依据。 |
||||||||||||||||||||||
|
Objectives of Study: |
The purpose of the study was to establish covid-19 exercise rehabilitation cohort, to analyze the therapeutic effect of rehabilitation therapy on cardiopulmonary function, motor function, activities of daily living, quality of life and psychology of patients discharged with COVID-19, and to provide evidence of evidence-based medicine for the formulation of covid-19 exercise rehabilitation methods. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
(1)体温>38°C |
||||||||||||||||||||||
|
Exclusion criteria: |
(1) body temperature>38 degree C |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2020-04-27 00:00:00至 To 2020-09-16 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2020-04-27 00:00:00 至 To 2020-06-07 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
本实验采用假随机方法,由门诊工作人员按患者就诊日期的单双号进行分组 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
In this experiment, a pseudo-random method was adopted, the patients will be divided into two groups according to the date of their visit. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
N/A |
|
Blinding: |
N/A |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
试验完成后6个月内在Resman上共享 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Within six months after the trial complate, Web-based pubulic database, Resman, http://www.medresman.org |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
数据采集和管理采用病例记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
A CRF will be used for data collection and management |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |